Tokyo, Oct. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063158) titled 'Preference Study for Schizophrenia Treatment Among Patients, Caregivers, and Physicians: A Discrete Choice Experiment' on Oct. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Schizophrenia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify the preference structures and relative importance of treatment attributes among patients with schizophrenia, their caregivers, and physicians.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender...